Lessons from the withdrawal of rofecoxib.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 15485938.
- Also identified by PMC identifier 523096.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients would be safer if drug companies disclosed adverse events before licensing
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Cyclooxygenase Inhibitors
- Drug Approval
- Lactones